Copyright © 2010 Philip J. Lupo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. L. D. Botto, A. Correa, and J. D. Erickson, “Racial and temporal variations in the prevalence of heart defects,” Pediatrics, vol. 107, no. 3, p. E32, 2001. View at Scopus
2. A. Christianson, C. P. Howson, and B. Modell, Global Report on Birth Defects, March of Dimes, White Plains, NY, USA, 2006.
3. K. J. Jenkins, A. Correa, J. A. Feinstein, et al., “Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics,” Circulation, vol. 115, no. 23, pp. 2995–3014, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
4. M. E. Pierpont, C. T. Basson, D. W. Benson Jr., et al., “Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics,” Circulation, vol. 115, no. 23, pp. 3015–3038, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
5. P. S. Harper, Practical Genetic Counselling, Hodder Arnold, New York, NY, USA, 2004.
6. L. E. Mitchell and C. R. Weinberg, “Evaluation of offspring and maternal genetic effects on disease risk using a family-based approach: the “pent” design,” American Journal of Epidemiology, vol. 162, no. 7, pp. 676–685, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
7. L. D. Botto, A. E. Lin, T. Riehle-Colarusso, S. Malik, and A. Correa, “Seeking causes: classifying and evaluating congenital heart defects in etiologic studies,” Birth Defects Research Part A, vol. 79, no. 10, pp. 714–727, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
8. E. Goldmuntz, S. Woyciechowski, D. Renstrom, et al., “Variants of folate metabolism genes and the risk of conotruncal cardiac defects,” Circulation, vol. 1, pp. 126–132, 2008. View at Publisher · View at Google Scholar · View at PubMed
9. C. A. Hobbs, S. J. James, A. Parsian, et al., “Congenital heart defects and genetic variants in the methylenetetrahydroflate reductase gene,” Journal of Medical Genetics, vol. 43, no. 2, pp. 162–166, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
10. G. M. Shaw, D. M. Iovannisci, W. Yang, et al., “Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes,” American Journal of Medical Genetics, vol. 138, no. 1, pp. 21–26, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
11. G. M. Shaw, W. Lu, H. Zhu, et al., “118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects,” BMC Medical Genetics, vol. 10, article 49, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
12. C. R. Weinberg, “Allowing for missing parents in genetic studies of case-parent triads,” American Journal of Human Genetics, vol. 64, no. 4, pp. 1186–1193, 1999. View at Publisher · View at Google Scholar · View at Scopus
13. K.-A. da Costa, O. G. Kozyreva, J. Song, J. A. Galanko, L. M. Fischer, and S. H. Zeisel, “Common genetic polymorphisms affect the human requirement for the nutrient choline,” FASEB Journal, vol. 20, no. 9, pp. 1336–1344, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
14. B. H. Rovin, L. Lu, and R. Saxena, “A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression,” Biochemical and Biophysical Research Communications, vol. 259, no. 2, pp. 344–348, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
15. P. Frosst, H. J. Blom, R. Milos, et al., “A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase,” Nature Genetics, vol. 10, no. 1, pp. 111–113, 1995. View at Scopus
16. I. Weisberg, P. Tran, B. Christensen, S. Sibani, and R. Rozen, “A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity,” Molecular Genetics and Metabolism, vol. 64, no. 3, pp. 169–172, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
17. D. L. Harmon, J. V. Woodside, J. W. G. Yarnell, et al., “The common ‘thermolabile’ variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia,” QJM, vol. 89, no. 8, pp. 571–577, 1996. View at Scopus
18. D. J. Gaughan, L. A. J. Kluijtmans, S. Barbaux, et al., “The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations,” Atherosclerosis, vol. 157, no. 2, pp. 451–456, 2001. View at Publisher · View at Google Scholar · View at Scopus
19. S. G. Heil, N. M. J. van der Put, E. T. Waas, M. Den Heijer, F. J. M. Trijbels, and H. J. Blom, “Is mutated serine hydroxymethyltransferase (SHMT) involved in the etiology of neural tube defects?” Molecular Genetics and Metabolism, vol. 73, no. 2, pp. 164–172, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. K. J. A. Lievers, L. A. Afman, L. A. J. Kluijtmans, et al., “Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients,” Clinical Chemistry, vol. 48, no. 9, pp. 1383–1389, 2002. View at Scopus
21. L. A. J. Kluijtmans, G. H. J. Boers, F. J. M. Trijbels, H. M. A. van Lith-Zanders, L. P. W. J. van den Heuvel, and H. J. Blom, “A common 844INS68 insertion variant in the cystathionine $\beta$-synthase gene,” Biochemical and Molecular Medicine, vol. 62, no. 1, pp. 23–25, 1997. View at Publisher · View at Google Scholar · View at Scopus
22. R. D. Kalmbach, S. F. Choumenkovitch, A. P. Troen, P. F. Jacques, R. D'Agostino, and J. Selhub, “A 19-base pair deletion polymorphism in dihydrofolate reductase is associated with increased unmetabolized folic acid in plasma and decreased red blood cell folate,” Journal of Nutrition, vol. 138, no. 12, pp. 2323–2327, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. H. Gellekink, H. J. Blom, I. J. M. van der Linden, and M. den Heijer, “Molecular genetic analysis of the human dihydrofolate reductase gene: relation with plasma total homocysteine, serum and red blood cell folate levels,” European Journal of Human Genetics, vol. 15, no. 1, pp. 103–109, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. H. Mei, M. L. Cuccaro, and E. R. Martin, “Multifactor dimensionality reduction-phenomics: a novel method to capture genetic heterogeneity with use of phenotypic variables,” American Journal of Human Genetics, vol. 81, no. 6, pp. 1251–1261, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. Q. Yang, M. J. Khoury, F. Sun, and W. D. Flanders, “Case-only design to measure gene-gene interaction,” Epidemiology, vol. 10, no. 2, pp. 167–170, 1999. View at Scopus
26. L.-Y. Wang and W.-C. Lee, “Population stratification bias in the case-only study for gene-environment interactions,” American Journal of Epidemiology, vol. 168, no. 2, pp. 197–201, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. D. M. Umbach and C. R. Weinberg, “The use of case-parent triads to study joint effects of genotype and exposure,” American Journal of Human Genetics, vol. 66, no. 1, pp. 251–261, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
28. J. K. Vermunt, LEM: A General Program for the Analysis of Categorical Data, Tilberg University, Tilberg, The Netherlands, 1997.
29. C. R. Weinberg, A. J. Wilcox, and R. T. Lie, “A log-linear approach to case-parent-triad data: assessing effects of disease genes that act either directly or through maternal effects and that may be subject to parental imprinting,” American Journal of Human Genetics, vol. 62, no. 4, pp. 969–978, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
30. V. M. Guillem, M. Collado, M. J. Terol, et al., “Role of MTHFR (677, 1298) haplotype in the risk of developing secondary leukemia after treatment of breast cancer and hematological malignancies,” Leukemia, vol. 21, no. 7, pp. 1413–1422, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. S. G. Reeves, C. Meldrum, C. Groombridge, et al., “MTHFR 677 $\text{C}>\text{T}$ and 1298 $\text{C}>\text{T}$ polymorphisms and the age of onset of colorectal cancer in hereditary nonpolyposis colorectal cancer,” European Journal of Human Genetics, vol. 17, no. 5, pp. 629–635, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
32. C. M. Summers, A. L. Hammons, L. E. Mitchell, et al., “Influence of the cystathionine $\beta$-synthase 844ins68 and methylenetetrahydrofolate reductase 677 $\text{C}>\text{T}$ polymorphisms on folate and homocysteine concentrations,” European Journal of Human Genetics, vol. 16, no. 8, pp. 1010–1013, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
33. V. de Stefano, V. Dekou, V. Nicaud, et al., “Linkage disequilibrium at the cystathionine $\beta$ synthase (CBS) locus and the association between genetic variation at the CBS locus and plasma levels of homocysteine,” Annals of Human Genetics, vol. 62, no. 6, pp. 481–490, 1998. View at Publisher · View at Google Scholar · View at Scopus
34. V. Dekou, V. Gudnason, E. Hawe, G. J. Miller, D. Stansbie, and S. E. Humphries, “Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men,” Thrombosis and Haemostasis, vol. 85, no. 1, pp. 67–74, 2001. View at Scopus
35. L. D. Botto and P. Mastroiacovo, “Exploring gene-gene interactions in the etiology of neural tube defects,” Clinical Genetics, vol. 53, no. 6, pp. 456–459, 1998. View at Scopus
36. E. Rampersaud, E. C. Melvin, D. Siegel, et al., “Updated investigations of the role of methylenetetrahydrofolate reductase in human neural tube defects,” Clinical Genetics, vol. 63, no. 3, pp. 210–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
37. B. Richter, K. Stegmann, B. Roper, et al., “Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population,” Journal of Human Genetics, vol. 46, no. 3, pp. 105–109, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
38. M. C. Speer, J. Nye, D. McLone, et al., “Possible interaction of genotypes at cystathionine $\beta$-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects,” Clinical Genetics, vol. 56, no. 2, pp. 142–144, 1999. View at Publisher · View at Google Scholar · View at Scopus